Moleculin Biotech, Inc. - Common Stock, par value $.001 per share (MBRX)

CUSIP: 60855D309

Q2 2024 13F Holders as of 30 Jun 2024

Holder snapshot 6 signals
Share change
+55,258
SEC-reported price per share
$3.52
Number of holders
15
Value change
+$192,754
Number of buys
10
Number of sells
6
Security identity Names, identifiers, and filing context for this profile. 1 source field
Shares outstanding
31,794,008

Security key

60855D309

Report period

Q2 2024

Institutions

15

Top holders

10

Ownership snapshot

Top reported holders of MBRX - Moleculin Biotech, Inc. - Common Stock, par value $.001 per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader
ARMISTICE CAPITAL, LLC
Disclosed value leader
ARMISTICE CAPITAL, LLC
Comparable rows
0/15
Latest evidence
31 Mar 2024
13F Highest disclosed value: $877,605 15 rows are not safely comparable across share classes. Showing 1-6 of 15 holder rows.

Quick read

ARMISTICE CAPITAL, LLC has the largest disclosed position value at $877.6K.

0 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens ARMISTICE CAPITAL, LLC's linked filing trail.
Disclosed position value Top 5
ARMISTICE CAPITAL, LLC $877.6K
VANGUARD GROUP INC $445K
GEODE CAPITAL MANAGEMENT, LLC $98.2K
BlackRock Finance, Inc. $73.7K
ATTICUS WEALTH MANAGEMENT, LLC $19.7K

Value bars compare disclosed positions; verify each figure against the linked filing evidence.

Detailed SEC evidence table Showing 1-6 of 15 holder rows
Holder Evidence Ownership % Position 12M Net Δ As of
ARMISTICE CAPITAL, LLC
13F
Company
13F
—
denominator unverified
$877,605
148,495 shares
— 31 Mar 2024
VANGUARD GROUP INC
13F
Company
13F
—
denominator unverified
$445,023
75,300 shares
— 31 Mar 2024
GEODE CAPITAL MANAGEMENT, LLC
13F
Company
13F
—
denominator unverified
$98,153
16,603 shares
— 31 Mar 2024
BlackRock Finance, Inc.
13F
Company
13F
—
denominator unverified
$73,715
12,473 shares
— 31 Mar 2024
ATTICUS WEALTH MANAGEMENT, LLC
13F
Company
13F
—
denominator unverified
$19,704
3,334 shares
— 31 Mar 2024
NFSG Corp
13F
Company
13F
—
denominator unverified
$4,048
685 shares
— 31 Mar 2024
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q2 2024

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions
15
Shares
313,722
Rows available
15
Investor Option Weight % Change % SEC-reported value * Price Shares Share Change Activity Report Period

* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q2 2024 vs Q3 2025 Across Filers

Q3 2025 holders
24
Q2 2024 holders
15
Holder diff
-9
Investor Q3 2025 Shares Q2 2024 Shares Share Diff Share Chg % Q3 2025 value Q2 2024 value Value change Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .